Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis - Results from the DANBIO Registry

Journal of Rheumatology

Volumn 39, Issue 1, 2012, Pages 46-53

  Jawaheer, Damini ^a   Olsen, Jeørn ^b,c   Hetland, Merete Lund ^d  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AARHUS UNIVERSITY   (Denmark)

^d Mental Health Services CPH   (Denmark)

Author keywords

Anti tumor necrosis factor response; Rheumatoid arthritis; Sex

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PREDNISOLONE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE REGISTRY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DENMARK; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855372573     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110548     Document Type: Article

References (25)

1. Silman AJ, Hochberg MC. Rheumatoid arthritis. Epidemiology of the rheumatic diseases. 2nd ed. Oxford; New York: Oxford University Press; 2001:31-70.
2. Forslind K, Hafstrom I, Ahlmen M, Svensson B. Sex: A major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 2007;66:46-52. (Pubitemid 46044859)
3. Ahlmen M, Svensson B, Albertsson K, Forslind K, Hafstrom I. Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage. Ann Rheum Dis 2010;69:230-3.
4. Leeb BF, Haindl PM, Maktari A, Nothnagl T, Rintelen B. Disease activity score-28 values differ considerably depending on patient's pain perception and sex. J Rheumatol 2007;34:2382-7. (Pubitemid 350230659)
5. Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study. Arthritis Res Ther 2009;11:R7.
6. Iikuni N, Sato E, Hoshi M, Inoue E, Taniguchi A, Hara M, et al. The influence of sex on patients with rheumatoid arthritis in a large observational cohort. J Rheumatol 2009;36:508-11.
7. Makinen H, Hannonen P, Sokka T. Sex: A major predictor of remission as measured by 28-joint Disease Activity Score (DAS28) in early rheumatoid arthritis? Ann Rheum Dis 2008;67:1052-3. (Pubitemid 351956679)
8. Kvien TK, Uhlig T, Odegard S, Heiberg MS. Epidemiological aspects of rheumatoid arthritis: The sex ratio. Ann NY Acad Sci 2006;1069:212-22. (Pubitemid 43989864)
9. Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PC, Ferrante A, Malesci D, et al. Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: The GISEA study. J Rheumatol 2007;34:1670-3. (Pubitemid 47267608)
10. Sokka T, Hetland ML, Makinen H, Kautiainen H, Horslev-Petersen K, Luukkainen RK, et al. Remission and rheumatoid arthritis: Data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008;58:2642-51.
11. Burmester GR, Ferraccioli G, Flipo RM, Monteagudo-Saez I, Unnebrink K, Kary S, et al. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study. Arthritis Rheum 2008;59:32-41. (Pubitemid 351171876)
12. van der Heijde D, Klareskog L, Landewe R, Bruyn GA, Cantagrel A, Durez P, et al. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 2007;56:3928-39. (Pubitemid 350262318)
13. Hyrich KL, Watson KD, Silman AJ, Symmons DP. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register. Rheumatology 2006;45:1558-65. (Pubitemid 44817065)
14. Jawaheer D, Maranian P, Park G, Lahiff M, Amjadi SS, Paulus HE. Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: Does gender matter? J Rheumatol 2010;37:2475-85.
15. Tengstrand B, Ahlmen M, Hafstrom I. The influence of sex on rheumatoid arthritis: A prospective study of onset and outcome after 2 years. J Rheumatol 2004;31:214-22. (Pubitemid 38160740)
16. Kuiper S, van Gestel AM, Swinkels HL, de Boo TM, da Silva JA, van Riel PL. Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol 2001;28:1809-16. (Pubitemid 32726927)
17. Karlsson JA, Kristensen LE, Kapetanovic MC, Gulfe A, Saxne T, Geborek P. Treatment response to a second or third TNF-inhibitor in RA: Results from the South Swedish Arthritis Treatment Group Register. Rheumatology 2008;47:507-13.
18. Hetland ML. DANBIO - powerful research database and electronic patient record. Rheumatology 2011;50:69-77.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
20. Department of Rheumatology, University Medical Centre, Nijmegen, the Netherlands. DAS-Score.NL. Home of the DAS. [Internet. Accessed Sept 15, 2011.] Available from: http://www.das-score.nl
21. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
22. van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40. (Pubitemid 26036375)
23. van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998;41:1845-50. (Pubitemid 28465539)
24. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304.
25. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-8.